Could Innovators Help Biosimilar Manufacturers?
This article was originally published in The Pink Sheet Daily
Executive Summary
J&J official suggests companies could share manufacturing advice with FDA to pass on to biosimilar applicants.
You may also be interested in...
FDA Searches For Clinical Trial Middle Ground At Biosimilar Hearing
FDA appeared to be searching for a way to limit the clinical trial requirements for biosimilars during a two-day public hearing on implementing a pathway for the products.
FDA Searches For Clinical Trial Middle Ground At Biosimilar Hearing
FDA appeared to be searching for a way to limit the clinical trial requirements for biosimilars during a two-day public hearing on implementing a pathway for the products.
Biosimilars On The Horizon: How Much Will FDA Look To The East?
Europe's pathway for follow-on biologics has selling points for both brand and generic firms, but FDA will chart its own course - even as it mulls accepting European data.